RECORDS ARE PUBLISHED REGULATORY ACTIONS. FIELDS THE ISSUING AUTHORITY DID NOT PUBLISH ARE MARKED AS NOT STATED, NEVER FILLED IN.
Drug Eye AfricaNational Actions, Continental Reach
Manufacturer profile

النصر

Every published regulatory action recorded against this manufacturer, across all African authorities Drug Eye Africa monitors. Built strictly from published regulatory decisions and nothing else.

What these numbers are. They are counts of published regulatory actions recorded on this register. They are not a finding about the company, not an allegation, and not a measure of product quality. A manufacturer appearing here has had actions published against named products by named authorities; the actions speak for themselves and each one links to its primary notice.
5
Recorded actions
1
Countries
1
Authorities
3
Class I actions recorded

Recorded actions

5 shown
ReferenceDateCountryProductBatchesActionClassSource
DEA-EG-2026-0010Jan 2026EGColchicine 0.5 mg tablet BP 2022
النصر
824725 · 834725RecallClass IIITier 1 · Regulator-published
DEA-EG-2025-0087Nov 2025EGHaemodialysis concentrate solution (biocarbonate)(1:35) (formula 1048)
النصر
37/48/2026 · 326/48/2025 · 36/48/2026 · 44/48/2026 · 45/48/2026RecallClass ITier 1 · Regulator-published
DEA-EG-2025-0081Oct 2025EGH.D.S (1048)
النصر للكيماويات الدوائية
354/48/2025RecallClass ITier 1 · Regulator-published
DEA-EG-2025-0036Jul 2025EGH.D.S(1048)
النصر
251/48/2025 · 252/48/2025 · 253/48/2025 · 205/48/2025 · 250/48/2025RecallClass ITier 1 · Regulator-published
DEA-EG-2024-0053Dec 2024EGمحلول مركز للغسيل الكلوي1047
El-nasr
206472023RecallUnclassifiedTier 1 · Regulator-published

Counts are of published regulatory actions recorded on this register. They are not a finding about the company, and this page says so.

Names as published

This profile groups 3 spellings used by the issuing authorities: النصر; النصر للكيماويات الدوائية; El-nasr.

Company response

Drug Eye Africa has not yet invited a response from this company. That is our omission and not the company’s silence, and it is recorded here as one.

A company named on this page may write to notices@drugeyeafrica.org. A response is published beside these records in full, and the request is logged either way. Nothing on this page is a finding about the company: each entry is an action a named authority published, and it links to that authority’s own notice.

How this page is built

  • Published regulator decisions only — no press reports, no allegations
  • Name matching is conservative: only corporate-form suffixes are stripped, and a name that would reduce to a single token is kept whole
  • Every action links to its primary notice

This profile as data

/api/v1/manufacturers/el-nasr

النصر · Drug Eye Africa